Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

21 Firstfield Road, Gaithersburg, United States

nikeita May. 16 at 11:09 AM

$NVAX Normally this combo would push CTB much higher. The most likely explanation is that large institutional holders are still supplying ample lendable shares through prime brokers, keeping the borrow market well fed despite the crowded short. So the key point it’s not a shortage of short demand, but a continued strong supply of stock available for lending. Convertible bonds can partially explain this dynamic, but it does not fully explain the entire picture on its own, nobody really knows why.

0 · Reply

redspring May. 16 at 10:27 AM

$NVAX

0 · Reply

ChannelGuru May. 16 at 9:33 AM

$NVAX Novavax institutional shareholding rises to 80.3%. Meanwhile shorts holding nearly 50m shares short at 30.5%.

0 · Reply

TobySmith1366 May. 16 at 4:57 AM

$NVAX THIS JUST HAPPENED :

0 · Reply

TobySmith1366 May. 16 at 4:56 AM

$NVAX Jesus CHRIST !!!!!!!!! $30 MONDAY PRE MARKET (IMO) https://www.youtube.com/watch?v=43MtedrHqyQ

1 · Reply

xjksks May. 16 at 2:39 AM

$NVAX https://www.cdhd.wa.gov/2026-05-15-newsroom-2026-02-confirmed-hantavirus-case-in-a-chelan-county-resident Confirmed case in the US

2 · Reply

xjksks May. 16 at 2:36 AM

$NVAX JUST IN: Congo confirms major Ebola outbreak, with 246 suspected cases.

1 · Reply

chloeworld5 May. 16 at 2:11 AM

$NVAX Dr. Tracy Beth Høeg played a key role in delaying and restricting the FDA approval of Novavax’s COVID-19 vaccine. Serving as a political appointee and special assistant to the U.S. Food and Drug Administration (FDA) Commissioner, she stepped in to re-examine Novavax's biological license application, disrupting the standard evaluation process typically handled by career

2 · Reply

SigmaMonark May. 16 at 1:41 AM

$NVAX loaded but left some extra cash in case it hits my 8.5 price as my last buy in.

1 · Reply

WhosYourDaddy_ May. 16 at 1:35 AM

$NVAX The smartest Baggie on this platform

0 · Reply

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA NVAX

May 7, 2026, 4:00 PM EDT - 8 days ago

Market Cap	1.54B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	184.60
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	-2.01

Volume	4,063,000
Avg Vol	4,371,146
Day's Range	N/A - N/A
Shares Out	164.44M
Stochastic %K	42%
Beta	2.37
Analysts	Sell
Price Target	$14.11